Skip to content Skip to footer
News

$5m gift to have “profound impact” on stroke and MND research

24 May 2017
Decorative

A $5 million donation to The University of Queensland’s prestigious Queensland Brain Institute (QBI) will transform the way world-leading researchers work with patients and doctors. 

UQ Vice-Chancellor Professor Peter Høj said the generous gift from The Brazil Family Foundation would support clinical collaborations in both stroke and motor neurone disease research. 

“This transformative donation from the Brazil family will extend the world-class stroke and motor neurone research being conducted at QBI,” Professor Høj said.

“Introducing a clinical arm to QBI enables clinicians and researchers to work side-by-side with patients to better understand and cure disease.”

QBI Director Professor Pankaj Sah said the gift would enhance the opportunity for QBI scientists to engage directly with patients.

“The Brazil family’s dedication and passion for understanding, managing and preventing neurological disease is inspiring,” Professor Sah said. 

“Their gift will have a profound impact on stroke and motor neurone disease research, and accelerate research through a cross-disciplinary approach.

“As part of QBI’s new clinical arm, I am pleased to announce the appointment of Professor Michael O’Sullivan, an eminent neurologist previously of King’s College, London.

“Professor O’Sullivan will drive QBI’s stroke research efforts, in addition to his new role as Director of the Mater (clinical) Centre for Neuroscience.”

Stroke affects more than 50,000 new Australians each year, is the nation’s third-biggest killer, and is estimated to cost the healthcare system $54 billion per annum.

Media: Donna Lu, communications@qbi.uq.edu.au, +61 405 661 856.

Related articles

Young children sitting around a table eating healthy snacks in a childcare setting.

Feed the children: food provision in early childcare falls short

A major report into Australia’s childcare services has recommended access to nutritionally adequate food be included in national quality standards.
11 November 2026
Portrait of Emeritus Professor Perry Bartlett standing smiling in a blue shirt.

National clinical trial for Australian-developed MND therapy

An Australian-developed therapy aimed at halting motor neurone disease progression and restoring function will advance to a national Phase 2 clinical trial.
10 November 2026

Media contact

Subscribe to UQ News

Get the latest from our newsroom.